Scientists from the Massachusetts Institute of Technology (MIT) have developed the first publicly available model for predicting the long-term stability of a cell type commonly used in biotherapeutic ...
Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
The CMS CGT Access Model involves 33 states, D.C., and Puerto Rico, focusing on sickle cell disease treatments for Medicaid beneficiaries. Outcomes-based contracts with manufacturers ensure discounts ...
Startup Somite AI announced today that it has raised over $47 million in a Series A funding round, bringing its total funding to about $60 million. The round was led by Khosla Ventures, with ...
Starting in his early teens, Deshawn "DJ" Chow wasn't sure he'd ever be able to live a normal life. Crushing pain episodes brought on by his sickle cell disease were getting progressively worse. "It's ...
In human cells, there are about 20,000 genes on a two-meter DNA strand—finely coiled up in a nucleus about 10 micrometers in diameter. By comparison, this corresponds to a 40-kilometer thread packed ...
A new breakthrough for spine and nervous system formation was successfully achieved by researchers where they were able to develop human stem cell models that will soon help in addressing the problems ...
One of the holy grails of biology is digitally simulating a living cell. If researchers can use computers to more accurately understand how new medicines would react in the body, that could give them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback